Study uncovers novel molecular mechanism of immune cell migration

In a new study, researchers from Osaka University discovered a novel molecular mechanism by which immune cells migrate to fight off infections. These findings may help in understanding the development of certain immune deficiency disorders and establish novel therapies against them.

Immune cells represent a diverse group of cells. Some circulate in the blood stream and migrate to infected tissues after receiving signals from damaged tissues. Others reside in tissues to take up the invading microbe, migrate to lymph nodes and activate an immune response. Therefore, to function effectively, the immune system's activities rely on motile cells. Immune cells move around the body via a process of repeated contraction and expansion, called actomyosin movement, involving myosin proteins. However, how this process of immune cell motility is governed remains unknown.

As simple as it sounds, cell migration is a highly regulated and complex process. A lot of individual pieces of the cell have to come together to allow immune cells to move forward and travel to infected sites of the body. Lysosomes are compartments within cells that are connected to nutrient sensing and metabolism, and they have also been shown to be involved in cell motility. We wanted to understand how lysosomes regulate the process of immune cell migration."

Takeshi Nakatani, Study's First Author

The researchers focused on a protein complex on lysosomes, called the Ragulator complex. To understand how the Ragulator complex regulates immune cell motility, the researchers used isolated dendritic cells. These cells take up microbial invaders and bring them to other immune cells in lymph nodes to activate an immune response. The researchers found that when the Ragulator complex interacts with a protein called MPRIP (myosin phosphatase Rho-interacting protein), it prevents the protein MLCP (myosin light chain phosphatase) from blocking the phosphorylation of myosin proteins, resulting in cell contraction. In doing so, the action of the Ragulator complex can be seen as a 'brake-release'.

Interestingly, the researchers found that cells migrate by repeated cycles of protrusions of their front and contraction of their rear, leading to a forward movement. However, in the absence of the Ragulator complex, cell contraction did not occur. In experiments with animals, the researchers found that without the Ragulator complex, dendritic cells cannot travel from peripheral tissue to lymph nodes, which results in an impaired immune response.

"These are striking results that show how the lysosomal Ragulator complex is involved in the migration of immune cells in addition to its functions in cellular metabolism. Our study revealed a novel molecular mechanism by which immune cells migrate and elicit a proper immune response. These findings could help develop novel therapies against autoimmune diseases as well as better vaccines and anti-cancer drugs," says senior author of the study Hyota Takamatsu.

Source:
Journal reference:

Nakatani, T., et al. (2021) The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II. Nature Communications. doi.org/10.1038/s41467-021-23654-3.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals tumor and immune cell interactions in craniopharyngiomas